Skip to the page

Data / Drug companies / Guaifenesin and dextromethorphan hbr

Guaifenesin and dextromethorphan hbr: 26 companies and 51 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Guaifenesin and dextromethorphan hbr is listed in the FDA National Drug Code Directory by 26 companies, with 51 products in commercial distribution. 48 of the products (94.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, and the newest product started marketing on October 27, 2026.

The request: Get every company that lists guaifenesin and dextromethorphan hbr in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
26
Products
51
Generic (ANDA) products
48 (94.1%)
Application numbers
6
Routes
Oral
Brand names
Mucus Relief DM, Mucus Relief Cough and Congestion DM, Mucus Relief DM, Maximum Strength Mucus Relief DM, Maximum Strength Cough and Congestion Extended Release, Mucus DM, Mucus Relief DM Expectorant and Cough Suppressant Maximum Strength, Members Mark Mucus Relief DM
openFDA record search
api.fda.gov

Companies that list guaifenesin and dextromethorphan hbr

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Aurohealth LLC6tablet, extended releaseGeneric drugs (ANDA)February 24, 2021
Dr. Reddy's Laboratories Inc.4tablet, extended releaseGeneric drugs (ANDA)August 15, 2023
Kroger Company4tablet, extended releaseGeneric drugs (ANDA)May 27, 2024
CVS Woonsocket Prescription Center, Incorporated3tablet, extended releaseGeneric drugs (ANDA)April 1, 2024
Ahold U.S.A., Inc2tablet, extended releaseGeneric drugs (ANDA)March 17, 2017
Amneal Pharmaceuticals LLC2tablet, extended releaseGeneric drugs (ANDA)November 1, 2018
CVS Pharmacy2tablet, extended releaseGeneric drugs (ANDA)March 17, 2017
Harris Teeter2tablet, extended releaseGeneric drugs (ANDA)August 16, 2024
Ohm Laboratories Inc.2tablet, extended releaseGeneric drugs (ANDA)July 1, 2021
Publix Super Markets, Inc2tablet, extended releaseGeneric drugs (ANDA)July 1, 2021
Safeway2tablet, extended releaseGeneric drugs (ANDA)March 17, 2017
Sportpharm LLC2tablet, extended releaseGeneric drugs (ANDA)March 17, 2017
Sun Pharmaceutical Industries, Inc.2tablet, extended releaseGeneric drugs (ANDA)July 1, 2021
Wal-Mart Stores Inc2tablet, extended releaseGeneric drugs (ANDA)March 17, 2017
Walgreen Company2tablet, extended releaseGeneric drugs (ANDA)March 17, 2017
WinCo Foods, LLC2tablet, extended releaseGeneric drugs (ANDA)March 17, 2017
Advance Pharmaceutical Inc.1tabletOver the counter monograph drugsAugust 1, 2017
Amazon.com Services LLC1tablet, extended releaseGeneric drugs (ANDA)May 15, 2024
Amerisource Bergen1tablet, extended releaseGeneric drugs (ANDA)August 7, 2017
Bryant Ranch Prepack1tabletOver the counter monograph drugsApril 1, 2016
Innovus Pharmaceuticals, Inc.1tablet, extended releaseGeneric drugs (ANDA)October 27, 2026
Richmond Pharmaceuticals, Inc.1tabletOver the counter monograph drugsApril 1, 2016
Sam's West Inc1tablet, extended releaseGeneric drugs (ANDA)August 15, 2023
Target Corporation1tablet, extended releaseGeneric drugs (ANDA)July 4, 2024
Topco Associates LLC1tablet, extended releaseGeneric drugs (ANDA)April 23, 2026
Vespyr Brands LLC1tablet, extended releaseGeneric drugs (ANDA)July 14, 2022

Dosage forms

Dosage formProductsShare
Tablet, extended release4894.1%
Tablet35.9%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)4894.1%
Over the counter monograph drugs35.9%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.